Arterial Ablation for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities
Clinical trial NCT05363761 · RECRUITING
Trial details
- NCT number
- NCT05363761
- Sponsor
- Neurotronic, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-19
- Primary completion
- 2025-01-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.